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Background. A novel ultrasensitive malaria rapid diagnostic test (us-RDT) has been developed for improved active Plasmodium 
falciparum infection detection. The usefulness of this us-RDT in clinical diagnosis and fever management has not been evaluated.
Methods. Diagnostic performance of us-RDT was compared retrospectively to that of conventional RDT (co-RDT) in 3000 
children and 515 adults presenting with fever to Tanzanian outpatient clinics. The parasite density was measured by an ultrasensitive 
qPCR (us-qPCR), and the HRP2 concentration was measured by an enzyme-linked immunosorbent assay.
Results. us-RDT identified few additional P. falciparum–positive patients as compared to co-RDT (276 vs 265 parasite-positive 
patients detected), with only a marginally greater sensitivity (75% vs 73%), using us-qPCR as the gold standard (357 parasite-positive 
patients detected). The specificity of both RDTs was >99%. Five of 11 additional patients testing positive by us-RDT had negative 
results by us-qPCR. The HRP2 concentration was above the limit of detection for co-RDT (>3653 pg of HRP2 per mL of blood) in 
almost all infections (99% [236 of 239]) with a parasite density >100 parasites per µL of blood. At parasite densities <100 parasites/
µL, the HRP2 concentration was above the limits of detection of us-RDT (>793 pg/mL) and co-RDT in 29 (25%) and 24 (20%) of 
118 patients, respectively.
Conclusion. There is neither an advantage nor a risk of using us-RDT, rather than co-RDT, for clinical malaria diagnosis. In 
febrile patients, only a small proportion of infections are characterized by a parasite density or an HRP2 concentration in the range 
where use of us-RDT would confer a meaningful advantage over co-RDT.
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Prompt detection and treatment of symptomatic and asympto-
matic malaria parasite infections is considered one of the key 
strategies to reduce transmission and accelerate malaria elimi-
nation. The large-scale deployment of conventional rapid diag-
nostic tests (co-RDTs) for detection of Plasmodium falciparum 
has considerably improved clinical case management of febrile 
patients [1]. Among other factors, such as age and previous ex-
posure to malaria parasite infection, the development of ma-
laria symptoms is mainly dependent on the parasite density in 
the blood of P. falciparum–infected individuals. The fraction of 
malaria-attributable fevers therefore increases with increasing 
parasite density [2]. Low-density P. falciparum parasitemia may 
be incidentally found in the blood of febrile patients but might 
not necessarily be the cause of fever in areas of high endemicity.
In contrast to malaria case management in clinical practice, 
intervention efforts for malaria elimination aim to identify 
asymptomatic parasite carriers. Asymptomatic carriers often 
harbor parasite densities below the limit of detection (LOD) 
of co-RDT or microscopy but contribute to maintaining ma-
laria transmission, particularly in areas of low endemicity [3]. 
Detection of asymptomatic carriers in research surveys there-
fore uses highly sensitive molecular diagnostic assays; however, 
molecular diagnostic methods require highly trained personnel 
and sophisticated laboratory infrastructure and are often not 
available in field settings.
To facilitate the detection of asymptomatic P.  falciparum 
infections in a point-of-contact manner, a novel ultrasensitive 
malaria RDT (us-RDT) was recently developed (Alere Malaria 
Ag P.f., Abbott Diagnostics). The analytical LOD of the us-RDT, 
at 80 pg of HRP2 per mL of blood, is 10-fold lower than that 
of co-RDT (800 pg/mL [4]) [5]. In community surveys in 
high-transmission (Uganda) and low-transmission (Myanmar) 
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settings, us-RDT identified 84% and 44% of polymerase chain 
reaction (PCR)–detected P.  falciparum infections, respectively, 
compared with 62% and 0%, respectively, for co-RDT [6]. A sub-
stantial gain in diagnostic sensitivity, from 25% for co-RDT to 
50%–51% for us-RDT, was observed also in other community 
surveys, in Myanmar [7] and Papua New Guinea [8], which used 
ultrasensitive molecular diagnostic assays as a gold standard.
The intended use of us-RDT is the detection of asymptomatic 
infections during active case detection interventions supporting 
elimination campaigns; however, there is a possibility that its 
use could be extended to case management of febrile patients. 
While maximizing the detection and treatment of all possible 
malaria parasite infections within the clinical surveillance sys-
tem, this off-label approach bears the risks of (1) misdiagnosis 
(ie, nonmalarial fevers might be attributed to a low-density inci-
dental P.  falciparum infection, owing to a positive test result) 
and, thus, inadequate treatment of the patient; (2) an increased 
number of false-positive test results due to the increased detec-
tion of residual HRP2 antigen, which persists >1 month in the 
circulation after clearance of a previous infection [9]; and (3) 
diversion of resources from management of true malaria cases, 
resulting in suboptimal patient care.
To quantify the potential effects of using us-RDT rather 
than co-RDT for case management of febrile patients, we ret-
rospectively compared the diagnostic performances of us-RDT 
and co-RDT in febrile children and adults attending outpatient 
clinics in Dar es Salaam, Tanzania. Using molecular quantifica-
tion, we defined the parasite density range that yields a positive 
RDT result and compared the limits of detection of us-RDT and 
co-RDT. Finally, we investigated the correlation of P. falciparum 
parasitemia level and HRP2 concentration in febrile individuals 
to explain the observed patterns in RDT positivity.
METHODS
Samples Collection and Study Design
Samples were obtained from 2 cohort studies in Dar es Salaam 
and analyzed retrospectively in a cross-sectional study design. 
Briefly, the cohorts included 3192 children aged 2–59 months 
presenting with acute febrile illness (axillary temperature, 
≥37.5°C) to 9 outpatient clinics between December 2014 and 
February 2016 [10] and 519 adults aged 18–80 years presenting 
with acute febrile illness (tympanic temperature, ≥38°C) to 4 
outpatient clinics between December 2013 and July 2014 [11]. 
Participants were managed using electronic and paper algo-
rithms derived from the integrated management of childhood 
or adolescent and adult illness. In both cohorts, participants 
were treated with antimalarial medicines on the basis of a posi-
tive co-RDT result, according to national guidelines.
Written informed consent was obtained from each caretaker 
or patient. The studies were approved by the Institutional Review 
Board of the Ifakara Health Institute (Dar Es Salaam, Tanzania), 
the National Institute for Medical Research Review Board (Dar 
Es Salaam, Tanzania), and the Ethikkommission Beider Basel 
(Basel, Switzerland); an additional approval was obtained from 
the Boston Children’s Hospital Ethical Review Board (Boston, 
MA) approved the study of the electronic algorithm [10].
Detection of P. falciparum Infections
Frozen venous whole blood specimens, stabilized in ethylenedi-
aminetetraacetic acid, aliquoted, and stored at −80°C on the day 
of sampling, were available for 3004 children and 515 adults. 
After shipment while frozen, samples were analyzed retrospec-
tively in the Swiss TPH laboratory, using 5 µL of whole blood for 
testing by co-RDT (Malaria Ag P.f., Abbott Diagnostics; refer-
ence 05FK50; lot 05CDB228A) and us-RDT (Alere Malaria Ag 
P.f., Abbott Diagnostics; reference 05FK140; lot 05LDB004A) 
according to the manufacturer’s instructions. RDTs were ini-
tially read, scored, and photographed by a laboratory techni-
cian. A second independent reader reviewed the photographs 
for double data entry. Discordant entries were resolved by a 
third reader, using photographs.
Molecular analysis of samples was performed using an 
ultra-sensitive quantitative PCR (us-qPCR) targeting the con-
served C-terminal region of the multiple-copy var gene family, 
which has a LOD <0.1 parasites per µL of blood [12]. DNA was 
extracted from 100 µL of whole blood by means of the DNeasy 
96 Blood and Tissue Kit (Qiagen), using an overnight proteinase 
K digest followed by loading and washing steps, according to the 
supplier’s instructions. DNA was eluted in 50 µL of elution buffer. 
Each 96-well extraction plate included 5 negative phosphate-buff-
ered saline controls. A total of 4 µL of DNA was used per us-qPCR 
reaction, corresponding to 8 µL of whole blood. Parasite density 
was determined using a 10-fold dilution row of the World Health 
Organization first international standard for P.  falciparum DNA 
nucleic amplification techniques (National Institute for Biological 
Standard and Control). For all samples with a parasitemia level 
<10 parasites/µL, DNA extraction was repeated, followed by 
us-qPCR analysis in duplicate. Samples with a parasite density <10 
parasites/µL were scored as positive for parasites only if they were 
confirmed as such during this second round of DNA extraction 
and us-qPCR analysis. For samples with confirmed positive test 
results, the geometric mean density based on all positive us-qPCR 
runs was reported as the final parasitemia level.
Quantification of HRP2
The concentration of HRP2 antigen was quantified in all 
us-qPCR- and/or RDT-positive samples and in 200 randomly 
selected us-qPCR- and RDT-negative samples. HRP2 quan-
tification was performed using a recently developed Q-plex 
array enzyme-linked immunosorbent assay (ELISA) kit, which 
was expanded from an earlier version of a multiplex ELISA 
(Quansys Biosciences [6]). Briefly, 12.5 µL of whole blood and 
37.5  µL of sample diluent (containing heterophilic antibodies 
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and rheumatoid factor blockers) were added to each plate well 
and incubated for 2 hours at room temperature while shaking 
at 500 rpm. After 3 washes, the plate was incubated with detec-
tion mix (50 µL/well, containing biotinylated detector antibod-
ies) for 1 hour while shaking. Following 3 washes, the plate 
was incubated with streptavidin–horseradish peroxidase (1×; 
50 µL/well) for 20 minutes while shaking. The plate was then 
washed 6 times, and the detection substrate mix (50  µL/well, 
consisting of equal volumes of stabilized hydrogen peroxide and 
stabilized signal enhancer) was added. The plate was imaged 
using a Q-view imager (Quansys Biosciences).
The upper limit of quantification, defined as the concentra-
tion above which HRP2 protein can be detected but not accu-
rately quantified, was 16 500 pg/mL. The lower analytical limit 
of quantification, defined as the concentration below which 
infections are considered HRP2 negative in this analysis, was 
1.07 pg/mL.
Data Analysis
Four children were excluded from the analysis because us-qPCR 
or HRP2 data could not be reproduced during quality control. 
The diagnostic performance of co-RDT and us-RDT were cal-
culated using us-qPCR as the reference standard. Logistic 
regression was used to estimate the lowest parasite density and 
HRP2 concentration at which an infection would be detected 
with 95% probability by co-RDT and us-RDT. For calculation of 
diagnostic sensitivity across the range of parasite densities and 
HRP2 concentrations, all observations were assigned a status 
of true positive, false positive, true negative, or false negative. 
Observations were sorted by parasite density or HRP2 concen-
tration, and a point estimate of sensitivity per parasite density 
or HRP2 concentration was calculated as a rolling mean in 
moving intervals of 18 observations, using the R-package zoo. 
All analyses were performed in R, version 3.4.3.
RESULTS
Diagnostic Performance of co-RDT and us-RDT
A positive co-RDT result was observed in 230 of 3000 children 
(7.7%) and 35 of 515 adults (6.8%; Table  1). In comparison, 
us-qPCR detected P. falciparum infections in 309 of 3000 chil-
dren (10.3%) and 48 of 515 adults (9.3%). us-RDT identified all 
patients with positive co-RDT results plus 9 additional children 
with positive co-RDT results (0.3% [9 of 3000]) and 2 additional 
adults (0.4% [2 of 515]). More than half of patients positive by 
us-RDT but negative by co-RDT (55% [6 of 11]) were also posi-
tive by us-qPCR. The remainder (45% [5 of 11]) were negative by 
Table 1. Positivity Counts and Diagnostic Performance of a Conventional Rapid Diagnostic Test (co-RDT) and an Ultrasensitive RDT (us-RDT) in Febrile 
Children and Adults from Tanzania
co-RDT
Children 
(n = 3000)
Adults 
(n = 515)
Status co-RDT Result us-qPCR Resulta No. No.
True positive + + 226 35
False positive + − 4 0
False negative − + 83 13
True negative − − 2687 467
Diagnostic performance Value (95% CI) Value (95% CI)
Sensitivity 73.1 (68.1–78.1) 72.9 (60.3–85.5)
Specificity 99.9 (99.7–1.00) 100.0 (100.0–100.0)
Positive predictive value 98.3 (96.6–1.00) 100.0 (100.0–100.0)
Negative predictive value 97.0 (96.4–97.6) 97.3 (95.8–98.7)
Positive likelihood ratio 492.0 (184.4–1313.1) Infinity
Negative likelihood ratio 0.3 (0.2–0.3) 0.3 (0.2–0.4)
us-RDT
Status us-RDT Result us-qPCR Resulta No. No.
True positive + + 230 37
False positive + − 9 0
False negative − + 79 11
True negative − − 2682 467
Diagnostic performance Value (95% CI) Value (95% CI)
Sensitivity 74.4 (69.6–79.3) 77.1 (65.2–89.0)
Specificity 99.7 (99.4–99.9) 100.0 (100.0–100.0)
Positive predictive value 96.2 (93.8–98.6) 100.0 (100.0–100.0)
Negative predictive value 97.1 (96.5–97.8) 97.7 (96.4–99.0)
Positive likelihood ratio 222.6 (115.5–428.7) Infinity
Negative likelihood ratio 0.26 (0.21–0.31) 0.2 (0.1–0.4)
Abbreviation: CI, confidence interval.
aUltrasensitive quantitative polymerase chain reaction (us-qPCR) was the gold standard.
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us-qPCR, suggesting detection of residual HRP2 after parasite 
clearance or parasite sequestration (Figure  1A). HRP2 ELISA 
confirmed the presence of HRP2 in these 5 samples (Figure 1B).
Owing to the low number of additional us-qPCR–positive 
specimens detected by us-RDT as compared to co-RDT, the 
gain in diagnostic sensitivity was low. The diagnostic sensitiv-
ity of co-RDT, using us-qPCR as the gold standard, was 73.1% 
(95% CI, 68.5%–77.7%) and did not differ between children 
(73.1% [95% CI, 68.1%–78.1%]) and adults (72.9% [95% CI, 
60.3%–85.5%]; χ2 P = .548; Table 1). For us-RDT, the sensitiv-
ity was 74.8% (95% CI, 70.3%–79.3%) overall, 74.4% (95% CI, 
69.6%–79.3%) in children, and 77.1% (95% CI, 65.2%–89.0%) 
in adults (χ2 P = .602).
The specificity of co-RDT and us-RDT, using us-qPCR as the 
gold standard, was >99% (Table 1), as the number of samples 
with a negative us-qPCR result and a positive co-RDT (n = 4) 
or us-RDT (n  =  9) result was low. No difference in specific-
ity was observed between adults and children. The positive 
predictive value was slightly higher for co-RDT (98.5% [95% 
CI, 97.0%–100%]) as compared to us-RDT (96.7% [95% CI, 
94.6%–98.8%]), while the negative predictive values were equal 
because of the high number of true-negative results (co-RDT, 
97.0% [95% CI, 96.4%–97.6%]; us-RDT, 97.2% [95% CI, 96.7%–
97.8%]). Agreement between the both RDTs was almost per-
fect, with a Cohen κ of 0.98. Both RDTs also agreed well with 
us-qPCR (Cohen κ, 0.82 for agreement with co-RDT and 0.83 
for agreement with us-RDT).
Sensitivity of co-RDT and us-RDT in Relation to Parasite Density and 
HRP2 Concentration
When comparing the LOD between the both RDTs, the parasite 
density detected by us-RDT was 2 times lower than that detected 
by co-RDT (Figure 2A). The LOD, defined as the lowest parasite 
density that could be detected with 95% probability, decreased 
from 626 parasites/µL (95% CI, 255–2066) for co-RDT to 346 
parasites/µL (95% CI, 142–1173) for us-RDT. When comparing 
the lowest reliably detected HRP2 concentration (Figure  2B), 
there was a larger (5-fold) difference between the two RDTs. The 
LOD was 793 pg HRP2/mL (95% CI, 363–1640) for us-RDT, 
compared with 3653 pg/mL (95% CI, 2527–4735) for co-RDT.
Owing to the low difference in the parasite density LOD 
between the two RDTs, the diagnostic sensitivity was compara-
ble across a wide parasite density range (Figure 2C). A gain in 
diagnostic sensitivity by using us-RDT was mainly observed for 
patients with a parasite density of 10–100 parasites/µL, reach-
ing a maximal gain of 12% (32% vs 44%) at 42 parasites/µL 
(Figure 2C). In contrast, when analyzing diagnostic sensitivity 
in relation to HRP2 concentration, a clear gain over the whole 
range of HRP2 concentrations was observed by using us-RDT 
as compared to co-RDT (Figure 2D), reaching a maximal gain 
of 43% (33% vs 76%) at 1317 pg/mL.
Distributions and Correlation of Parasite Density and HRP2 Concentration
The parasite density (detected by us-qPCR) and the HRP2 con-
centration (detected by ELISA) in febrile children and febrile 
adults followed a bimodal distribution (Figure 3). The distribu-
tion of the parasite density was characterized by 2 pronounced 
peaks and a trough at 100–1000 parasites/µL (Figure  3A and 
3B). In contrast, the distribution of the HRP2 concentration 
exhibited 1 major peak, at 10 000 pg/mL, and 1 minor peak, 
at 1–100 pg/mL (Figure 3C and 3D). No linear correlation was 
observed between parasite density and HRP2 concentration in 
children or adults (Spearman ρ, 0.36 for both groups; Figure 4).
The parasite density was lower in adults (geometric mean, 
1102 parasites/µL; median, 1691 parasites/µL [IQR, 27–87 
812 parasites/μL]) as compared to children (geometric mean, 
3844 parasites/µL; median, 54 742 parasites/μL [IQR, 13–385 
514 parasites/μL]; Mann-Whitney U P  =  .042). Also, the 
HRP2 concentration was lower in adults as compared to chil-
dren, although there was little difference in the median HRP2 
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Figure 1.  Venn diagram of Plasmodium falciparum positivity by different diagnostic methods. A, Positivity by a conventional rapid diagnostic test (co-RDT), an ultrasensi-
tive RDT (us-RDT), and an ultrasensitive quantitative polymerase chain reaction (us-qPCR) in 3515 febrile children and adults attending outpatient clinics in Dar es Salaam, 
Tanzania. B, Positivity by RDT, us-qPCR, and an HRP2 enzyme-specific immunosorbent assay (ELISA) in the subset of 566 children and adults who were tested by HRP2 ELISA. 
For RDT positivity, the larger, continuous circle delineates positivity by us-RDT, and the smaller, dashed circle delineates positivity by co-RDT.
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concentration between the 2 groups (adults, 6472 pg/mL [IQR, 
86–7853 pg/mL]; children, 7933 pg/mL [IQR, 6653–9924 pg/
mL]; Mann-Whitney U P < .001).
RDT Positivity in Relation to HRP2 Concentration and Parasitemia Level in 
Children Versus Adults
The concentration of HRP2 was >3653 pg/mL, which is above 
the co-RDT LOD, in practically all children and adults (99% [207 
of 210] and 100% [29 of 29], respectively) with a parasitemia level 
of >100 parasites/µL (Figure 4). These infections were thus gener-
ally detected by co-RDT (98% of patients [235 of 239] tested pos-
itive), and the gain in positivity by using us-RDT was marginal 
(99% [236 of 239] tested positive; McNemar χ2 P = 1.000).
Among 118 febrile children and adults with a parasite density 
<100 parasites/µL, the HRP2 concentration varied substantially, 
ranging from 1.1 to >16 500 pg/mL (median, 409 pg/mL [IQR, 
8–9991 pg/mL]; Figure 4). The HRP2 concentration was above 
the co-RDT LOD in 20% of patients (24 of 118) and above the 
us-RDT LOD in an additional 4% (5 of 118). Hence, in infec-
tions with parasitemia <100 parasites/μL there was only a small 
and nonsignificant increase in the proportion of patients with 
RDT-detectable infections detected by us-RDT (26% of patients 
[31 of 118] tested positive) as compared to co-RDT (22% [26 
of 118] tested positive; McNemar χ2 P = .074).
In 81 patients with very low-density infections (parasitemia 
level, <10 parasites/µL), a similar variation in HRP2 concentra-
tion was observed in children (median, 37 pg/mL [IQR, 3–13 
800 pg/mL]; n = 73; Figure 4A) but not in adults (Figure 4B). 
Instead, very low-density infections in adults were characterized 
by a low HRP2 concentration (median, 14 pg/mL [IQR, 6–42 
pg/mL]; n  =  8). As a result, very low-density infections with 
a positive co-RDT or us-RDT result were almost exclusively 
found in children (93% [14 of 15]). Coherently, a high HRP2 
concentration and positive co-RDT or us-RDT results among 
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Figure 2. Limit of detection and diagnostic sensitivity of a conventional rapid diagnostic test (co-RDT) and an ultrasensitive RDT (us-RDT) in relation to parasite density 
and HRP2 concentration. A and B, Relationship between the probability of testing positive for Plasmodium falciparum by co-RDT and us-RDT and parasite density (A) or HRP2 
concentration (B). Shaded areas represent 95% confidence intervals (CIs) of the logistic regression model. C and D, Diagnostic sensitivity of co-RDT and us-RDT in relation 
to parasite density (C) and HRP2 concentration (D). Diagnostic sensitivities were calculated as a rolling means of 18 observations, using us-qPCR as a gold standard, and are 
shown with 95% CIs (shaded areas). Curves were smoothed using the lowess function (span, 0.05).
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us-qPCR–negative samples were exclusively found in children 
(median, 3336 pg/mL [IQR, 2112–8550 pg/mL]; n = 9).
Among 200 patients with negative results in us-qPCR, 
us-RDT, and co-RDT, HRP2 was detected in 11 (5.5%). The 
concentration of HRP2 in these patients ranged from 1.2 to 65.4 
pg/mL (Figure 3C and 3D and Figure 4). Low levels of residual 
circulating HRP2 can therefore remain in the blood even in ab-
sence of us-qPCR–detectable parasitemia. However, parasite 
DNA was detected in 73% of samples (29 of 40) with a compa-
rably low HRP2 concentration (<100 pg/mL), suggesting that 
in the majority of cases, low-level HRP2 in febrile children and 
adults originates from a concurrent low-density P.  falciparum 
infection.
DISCUSSION
Only a few additional P.  falciparum–positive febrile patients 
were detected by us-RDT compared to co-RDT in 2 age cohorts, 
comprising 3000 children and 515 adults, presenting to outpa-
tient clinics in an urban setting in Tanzania. This resulted in a 
minimal gain of 2% in diagnostic sensitivity by using us-RDT, 
with no difference between adults and children. Such a small 
gain is explained by the small proportion of symptomatic ma-
laria parasite infections (10% [37 of 357]) with a parasite den-
sity in the range of 10–100 parasites/µL, for which the use of 
us-RDT would confer a meaningful improvement over co-RDT. 
This implies that there is a limited increase in sensitivity associ-
ated with the use of us-RDT in the management of febrile cases 
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Figure  3. Distributions of parasite density and HRP2 concentration in febrile children and adults attending outpatient clinics in Dar es Salaam, Tanzania. A and B, 
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but also a limited risk of a positive us-RDT result masking other 
underlying causes of fever and misleading clinicians.
Our results confirm a previous evaluation of the utility of 
us-RDT in different target populations, which estimated that 
improving the RDT LOD from 3000 pg/mL to 200 pg/mL would 
yield an additional 50%–60% of RDT-positive results among 
afebrile individuals but would only have a limited effect, with 
10%–20% extra RDT-positive results, among febrile patients 
[13]. In our survey of febrile patients, where we estimated the 
LOD of co-RDT to be 3653 pg/mL and that of us-RDT to be 793 
pg/mL, we found an additional 4% of parasite-positive patients 
(11 of 265)  by using us-RDT as compared to co-RDT. The 
comparably high LOD estimates in the study presented here, 
compared with the previously described LOD of 80 pg/mL for 
us-RDT [5] and 800 pg/mL for co-RDT [4], may be explained 
by the choice of study population: in febrile patients, samples 
from only a few patients (10% [34 of 319] with positive HRP2 
ELISA results) yielded an HRP2 concentration of 100–1000 pg/
mL, while most samples were characterized by either very low 
(in patients with nonmalarial fever) or very high (in patients 
with malaria-attributable fever) HRP2 concentrations. This 
may have contributed to uncertainty in the LOD estimation.
The low gain in sensitivity by using us-RDT seems specific 
for diagnosing clinical malaria in febrile patients. In contrast, 
in previous cross-sectional surveys in asymptomatic individ-
uals, a much higher percentage of additional positives (range, 
35%–100%) was found [6–8]. The difference in the propor-
tion of additional positive results among afebrile individuals as 
compared to febrile patients reflects the difference in parasite 
density distributions in the 2 populations. While parasite den-
sities were normally distributed, with a maximum at 100–1000 
parasites/µL, in the community surveys of afebrile individuals 
[6–8], in this survey of febrile patients we observed a bimodal 
distribution, with a trough at 100–1000 parasites/µL. Also, a re-
cent study in pregnant Columbian women found that the use of 
us-RDT increased the diagnostic sensitivity (using nested PCR 
as the gold standard) in afebrile participants but not sympto-
matic participants when compared to co-RDT or microscopy.
Similarly, the correlation of parasite density and HRP2 con-
centration and, thus, RDT positivity seems to differ between 
different target populations and endemicity levels. While the 
parasite density and HRP2 concentration were linearly cor-
related (after log10 transformation) [7] or exhibited similar 
distributions [6] in 2 community surveys in areas of Myanmar 
with low malaria endemicities, this was not the case in our sur-
vey of febrile Tanzanian patients and in a community survey in 
an area of high endemicity in Uganda [6]. Instead, in the latter 
2 populations, very high concentrations of HRP2 (>10 000 pg/
mL) were the most common observations, and a steep, stepwise 
increase in the HRP2 concentration was observed at parasite 
densities >100 parasites/µL. In the high-transmission setting of 
Uganda, high levels of HRP2 in asymptomatic individuals are 
likely due to residual circulating HRP2 in frequently infected 
individuals. HRP2 is stable in the blood, with a half-life of 
3–15 days after treatment, and can be detected for >1 month 
after antimalarial treatment [14, 15]. It is possible that residual 
HRP2 originating from a previous but cleared malaria parasite 
infection would also be detectable by RDTs in febrile patients 
presenting to clinics in high-transmission settings. This could 
potentially give rise to a greater increase in the detection of 
parasite-positive patients with us-RDT use in a clinical setting, 
compared with the minimal gain in low-transmission settings.
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Figure 4. Correlation of parasite density and HRP2 concentration in febrile children (A) and febrile adults (B) attending outpatient clinics in Dar es Salaam, Tanzania. Data 
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In the survey of febrile Tanzanian patients presented here, a 
high HRP2 concentration in patients with low parasitemia lev-
els or even negative results of us-qPCR were observed in only 
a few children and no adults. This could be explained either by 
the much larger sample size of children as compared to adults 
or by biological factors related to antimalarial immunity in chil-
dren. First, P. falciparum sequestration is more pronounced in 
children as compared to adults, leading to intermittent absence 
of the parasite from the peripheral blood in synchronous infec-
tions [16] while HRP2 remains in the circulation. Second, 
young children experience a higher peak parasitemia level 
upon infection as compared to adults, because their acquired 
immunity to malaria is lower and, thus, their parasite density is 
less controlled [17]. As the initial peak parasitemia level is the 
main determining factor influencing the duration of persistent 
RDT positivity after antimalarial treatment [15], young chil-
dren remain RDT positive longer after antimalarial treatment, 
compared with adults [14].
Increased detection of residual HRP2 by us-RDT as com-
pared to co-RDT is considered as one of the main risks asso-
ciated with the use of us-RDT in clinical case management. In 
our survey, use of us-RDT doubled the number RDT-positive 
but us-qPCR–negative patients in comparison to co-RDT (4 
vs  9). However, RDT-positive, us-qPCR–negative patients 
were rare, compared with the number of RDT-positive patients 
with malaria confirmed by us-qPCR (co-RDT,  261; us-RDT, 
267). Also, diagnostic specificity was high (>99%) for us-RDT, 
owing to the very large number of correctly identified negatives 
(co-RDT, 3154; us-RDT, 3149).
A limitation of our study is the use of frozen venous blood 
samples. These may perform differently when analyzed by RDT, 
compared with fresh capillary blood specimens [18], but are 
nevertheless frequently used in diagnostic assessment of RDTs 
[4, 18], such as in previous studies evaluating us-RDT [6, 19]. 
Aliquoted at collection, our samples underwent ≤2 freeze-
thaw cycles before analysis. In previous studies, such a limited 
number of freeze-thaw cycles did not affect the performance of 
HRP2 ELISA [20, 21] or HRP2 dipstick analysis [22].
The present article does not focus on the relevance of detect-
ing and treating co-RDT–negative P.  falciparum infections in 
febrile patients, which is discussed elsewhere (Hartley et  al, 
unpublished data). Our previous studies showed an absence of 
clinical complications due to untreated malaria parasite infec-
tion after a negative co-RDT result in febrile Tanzanian chil-
dren [23] and returning travelers [24]. This suggests that using 
ultrasensitive tests is not required in clinical case management.
In conclusion, our results show that the potential advantage and 
harm are minimal from the off-label use of us-RDT as a diagnos-
tic assay in clinical practice and for malaria case management in 
areas of low endemicity, such as Dar es Salaam (prevalence, 1.1% 
in children aged 6–59 months [25]). us-RDT increases diagnostic 
sensitivity mainly around a parasite density of 100 parasites/µL; 
however, in low-transmission settings, infections with this par-
asite density are rarely found in febrile patients. Conversely, the 
risk of an increased frequency of malaria misdiagnosis is low 
when using us-RDT rather than co-RDT for detection of P. fal-
ciparum in clinical practice in areas of low endemicity. While 
our results are reassuring for clinical practitioners, they require 
validation in different transmission settings, including an eval-
uation of clinical outcomes in P.  falciparum–positive patients 
whose infection is not detected by co-RDT.
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